Thanks Cranswick...this one and FMG is holding up my portfolio at the moment...was tempted to sell but can see its on a run.regards Rosse
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling